Leafix Medical
Transcatheter Solution to Functional Mitral Regurgitation
StartupLeafix Medical is a Givat Brenner-based startup in the Health Tech & Life Sciences sector, established in 2025. Transcatheter Solution to Functional Mitral Regurgitation. The company has raised a total of $6.5M across 2 funding rounds, currently at the Seed stage. Leafix Medical was founded by Ron Szekely. Key investors include Pitango HealthTech. The company has 1-10 employees. Core technologies: Materials & Substances, Implants.
With $6.5M in total funding, Leafix Medical is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.
- StageSeed
- ProductR&D
- ModelB2B
- Employees1-10
- HQGivat Brenner
- DistrictCenter District
- Last Round$5M
- Pitango HealthTechLead
Ron SzekelyCo-founder & CEO
1 article covered by sources including www.calcalist.co.il.
What does Leafix Medical do?
LeaFix developed the only Transcatheter Functional Mitral valve Regurgitation repair solution, performed by an augmentation of the anterior leaflet. The system is composed of an implant and a delivery system, used for implantation of an implant into the anterior leaflet while expanding the implant within the leaflet, hence enlarging the leaflet area and creating coaptation of the leaflets.
How much funding has Leafix Medical raised?
Leafix Medical has raised $6.5M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Pitango HealthTech.
Who founded Leafix Medical ?
Leafix Medical was founded in 2025 by Ron Szekely (Co-founder & CEO).
What sector is Leafix Medical in?
Leafix Medical operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Leafix Medical located?
Leafix Medical is based in Givat Brenner, Israel, Center District.